Lazard Asset Management LLC Deciphera Pharmaceuticals, Inc. Transaction History

Lazard Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.58 - $17.36 $7,319 - $9,357	-539 Reduced 4.91%	10,445 $164,000
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $2,598 - $4,250	257 Added 2.4%	10,984 $177,000
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $133,658 - $166,053	10,727 New	10,727 $136,000
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $120,083 - $186,104	8,421 New	8,421 $130,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $46,561 - $76,085	3,761 New	3,761 $69,000
Q2 2022 Aug 09, 2022	SELL	$9.11 - $13.98 $56,318 - $86,424	-6,182 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.87 - $11.11 $42,470 - $68,682	6,182 New	6,182 $57,000
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $46,013 - $64,603	-1,739 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$32.73 - $47.95 $23,369 - $34,236	714 Added 69.66%	1,739 $63,000
Q1 2021 May 14, 2021	BUY	$40.39 - $56.73 $41,399 - $58,148	1,025 New	1,025 $45,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.